BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11468555)

  • 1. Combined FTY720/cyclosporine treatment promotes graft survival and lowers the peripheral lymphocyte count in a murine cardiac allotransplantation model.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transplantation; 2001 Jul; 72(1):168-71. PubMed ID: 11468555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transpl Immunol; 2000 Jun; 8(2):115-24. PubMed ID: 11005317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of SDZ RAD compared with CsA monotherapyand combined Rad/FTY720 treatment in a murine cardiac allotransplantation model.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transpl Immunol; 2001 Oct; 9(1):43-9. PubMed ID: 11680571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
    Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.
    Schuurman HJ; Menninger K; Audet M; Kunkler A; Maurer C; Vedrine C; Bernhard M; Gaschen L; Brinkmann V; Quesniaux V
    Transplantation; 2002 Oct; 74(7):951-60. PubMed ID: 12394836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation.
    Hwang MW; Matsumori A; Furukawa Y; Ono K; Okada M; Iwasaki A; Hara M; Sasayama S
    Circulation; 1999 Sep; 100(12):1322-9. PubMed ID: 10491378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation.
    Wang MH; Milekhin V; Zhang H; Huang HZ
    Acta Pharmacol Sin; 2003 Sep; 24(9):847-52. PubMed ID: 12956930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate.
    Chiba K; Hoshino Y; Ohtsuki M; Kataoka H; Maeda Y; Matsuyuki H; Sugahara K; Kiuchi M; Hirose R; Adachi K
    Transplant Proc; 2005; 37(1):102-6. PubMed ID: 15808561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of mycophenolate sodium as monotherapy and in combination with FTY720 in a DA-to-Lewis-rat heart-transplantation model.
    Matsumoto Y; Hof A; Baumlin Y; Hof RP
    Transplantation; 2002 Nov; 74(10):1372-6. PubMed ID: 12451233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
    Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model.
    Nikolova Z; Hof A; Rudin M; Baumlin Y; Kraus G; Hof RP
    Transplantation; 2000 Jun; 69(12):2525-30. PubMed ID: 10910272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with Cyclosporine Neoral or with RAD.
    Quesniaux VF; Menninger K; Kunkler A; Vedrine C; Bernhard M; Hedinger R; Kraus G; Schuurman HJ
    Transpl Immunol; 2000 Nov; 8(3):177-87. PubMed ID: 11147698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
    Troncoso P; Stepkowski SM; Wang ME; Qu X; Chueh SC; Clark J; Kahan BD
    Transplantation; 1999 Jan; 67(1):145-51. PubMed ID: 9921811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus in combination with FTY720--an analysis of renal and blood parameters.
    Gallo AP; Silva LB; Franco M; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1919-24. PubMed ID: 17219691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.
    Chiba K; Yanagawa Y; Masubuchi Y; Kataoka H; Kawaguchi T; Ohtsuki M; Hoshino Y
    J Immunol; 1998 May; 160(10):5037-44. PubMed ID: 9590253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K
    J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
    Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.